• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌免疫浸润特征及其临床意义:综合基因组分析。

Profiles of Immune Infiltration in Bladder Cancer and its Clinical Significance: an Integrative Genomic Analysis.

机构信息

Department of Urology, Qilu Hospital of Shandong University, Jinan, P.R. China.

Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, P.R. China.

出版信息

Int J Med Sci. 2020 Mar 5;17(6):762-772. doi: 10.7150/ijms.42151. eCollection 2020.

DOI:10.7150/ijms.42151
PMID:32218698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7085262/
Abstract

Tumor-infiltrating immune cells are closely related to the prognosis of bladder cancer. Analysis of tumor infiltrating immune cells is usually based on immunohistochemical analysis. Since many immune cell marker proteins are not specific for different immune cells, which may induce misleading or incomplete. CIBERSORT is an algorithm to estimate specific cell types in a mixed cell population using gene expression data. In this study, the CIBERSORT algorithm was used to identify the immune cell infiltration signatures. The gene expression profiles, mutation data, and clinical data were collected from The Cancer Genome Atlas (TCGA) database. Unsupervised consensus clustering was used to acquire the immune cell infiltration subtypes of bladder cancer based on the fractions of 22 immune cell types. Four immune cell clusters with different immune infiltrate and mutation characteristics were identified. In addition, this stratification has a prognostic relevance, with cluster 2 having the best outcome, cluster 1 the worst. These clusters showed distinct mRNA expression patterns. The characteristic genes in subtype cluster 1 were mainly involved in cell division, those in subtype cluster 2 were mainly related in antigen processing and presentation, those in subtype cluster 3 were mainly involved in epidermal cell differentiation, and those in subtype cluster 4 were mainly related in the humoral immune response. These differences may affect the development of the bladder cancer, the sensitivity to treatment as well as the prognosis. Through further validation, this study may contribute to the development of personalized therapy and precision medical treatments.

摘要

肿瘤浸润免疫细胞与膀胱癌的预后密切相关。肿瘤浸润免疫细胞的分析通常基于免疫组织化学分析。由于许多免疫细胞标志物蛋白对不同的免疫细胞并不特异,这可能会导致误导或不完整。CIBERSORT 是一种使用基因表达数据估计混合细胞群体中特定细胞类型的算法。在这项研究中,使用 CIBERSORT 算法来识别免疫细胞浸润特征。从癌症基因组图谱 (TCGA) 数据库中收集基因表达谱、突变数据和临床数据。基于 22 种免疫细胞类型的分数,使用无监督共识聚类来获得膀胱癌的免疫细胞浸润亚型。鉴定出具有不同免疫浸润和突变特征的 4 种免疫细胞簇。此外,这种分层具有预后相关性,簇 2 具有最好的结果,簇 1 最差。这些簇显示出不同的 mRNA 表达模式。亚型簇 1 中的特征基因主要参与细胞分裂,亚型簇 2 中的特征基因主要与抗原加工和呈递有关,亚型簇 3 中的特征基因主要与表皮细胞分化有关,亚型簇 4 中的特征基因主要与体液免疫反应有关。这些差异可能影响膀胱癌的发展、治疗敏感性和预后。通过进一步验证,本研究可能有助于个性化治疗和精准医疗的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d012/7085262/2675f1f2cd76/ijmsv17p0762g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d012/7085262/7027cc1eae0b/ijmsv17p0762g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d012/7085262/c91f123e445b/ijmsv17p0762g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d012/7085262/fd755cf9464e/ijmsv17p0762g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d012/7085262/ed21fbc3bcc5/ijmsv17p0762g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d012/7085262/2675f1f2cd76/ijmsv17p0762g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d012/7085262/7027cc1eae0b/ijmsv17p0762g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d012/7085262/c91f123e445b/ijmsv17p0762g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d012/7085262/fd755cf9464e/ijmsv17p0762g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d012/7085262/ed21fbc3bcc5/ijmsv17p0762g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d012/7085262/2675f1f2cd76/ijmsv17p0762g005.jpg

相似文献

1
Profiles of Immune Infiltration in Bladder Cancer and its Clinical Significance: an Integrative Genomic Analysis.膀胱癌免疫浸润特征及其临床意义:综合基因组分析。
Int J Med Sci. 2020 Mar 5;17(6):762-772. doi: 10.7150/ijms.42151. eCollection 2020.
2
Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer.鉴定膀胱癌低肿瘤突变负荷组和高肿瘤突变负荷组之间的基因表达谱和免疫细胞浸润特征。
Int J Med Sci. 2020 Jan 1;17(1):89-96. doi: 10.7150/ijms.39056. eCollection 2020.
3
Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.从 TCGA 数据库挖掘肿瘤突变负荷及其在膀胱癌中的临床意义。
Biosci Rep. 2020 Apr 30;40(4). doi: 10.1042/BSR20194337.
4
Clinical and molecular characteristics of bladder urothelial carcinoma subtypes.膀胱尿路上皮癌亚型的临床和分子特征
J Cell Biochem. 2019 Jun;120(6):9956-9963. doi: 10.1002/jcb.28278. Epub 2018 Dec 12.
5
Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis.建立一种新的风险评分模型,通过全面分析膀胱癌免疫原数据库,以指示临床意义并预测预后。
Aging (Albany NY). 2020 Jun 22;12(12):11967-11989. doi: 10.18632/aging.103364.
6
Tumor‑infiltrating M2 macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer.特定基因组改变驱动的肿瘤浸润性 M2 巨噬细胞与膀胱癌的预后相关。
Oncol Rep. 2019 Aug;42(2):581-594. doi: 10.3892/or.2019.7196. Epub 2019 Jun 12.
7
Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma.鉴定膀胱癌中的预后免疫基因。
Biomed Res Int. 2020 Jan 20;2020:7510120. doi: 10.1155/2020/7510120. eCollection 2020.
8
Construction of Decision Trees Based on Gene Expression Omnibus Data to Classify Bladder Cancer and Its Subtypes.基于基因表达综合数据库构建决策树以分类膀胱癌及其亚型。
Med Sci Monit. 2021 Mar 23;27:e929394. doi: 10.12659/MSM.929394.
9
Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.靶向 DNA 和 RNA 测序联合分析尿路上皮癌和鳞状细胞膀胱癌揭示了不同的基因组和转录组事件以及独特的治疗意义。
Eur Urol. 2018 Dec;74(6):741-753. doi: 10.1016/j.eururo.2018.06.047. Epub 2018 Jul 20.
10
Classification of bladder cancer based on immune cell infiltration and construction of a risk prediction model for prognosis.基于免疫细胞浸润的膀胱癌分类和预后风险预测模型的构建。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023 Dec 24;53(1):47-57. doi: 10.3724/zdxbyxb-2023-0343.

引用本文的文献

1
Tumor hypoxia in immune infiltration and prognosis of bladder cancer.肿瘤缺氧在膀胱癌免疫浸润及预后中的作用
Transl Cancer Res. 2024 Jul 31;13(7):3273-3284. doi: 10.21037/tcr-23-2375. Epub 2024 Jul 26.
2
Digital spatial profiling of the microenvironment of muscle invasive bladder cancer.数字空间分析浸润性膀胱癌的微环境。
Commun Biol. 2024 Jun 18;7(1):737. doi: 10.1038/s42003-024-06426-9.
3
A transcriptome study of p53-pathway related prognostic gene signature set in bladder cancer.膀胱癌中p53信号通路相关预后基因特征集的转录组研究

本文引用的文献

1
Molecular and histopathology directed therapy for advanced bladder cancer.分子病理导向的晚期膀胱癌治疗。
Nat Rev Urol. 2019 Aug;16(8):465-483. doi: 10.1038/s41585-019-0208-0. Epub 2019 Jul 9.
2
Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays.多中心分析性比较研究使用四种临床开发的免疫组织化学检测方法,检测尿路上皮膀胱癌肿瘤浸润免疫细胞和肿瘤细胞程序性死亡配体 1 的表达。
Virchows Arch. 2019 Nov;475(5):599-608. doi: 10.1007/s00428-019-02610-z. Epub 2019 Jul 2.
3
Heliyon. 2023 Oct 14;9(10):e21058. doi: 10.1016/j.heliyon.2023.e21058. eCollection 2023 Oct.
4
Clinical Exome Gene Panel Analysis of a Cohort of Urothelial Bladder Cancer Patients from Sri Lanka.斯里兰卡膀胱癌患者队列的临床外显子组基因分析。
Asian Pac J Cancer Prev. 2023 May 1;24(5):1533-1542. doi: 10.31557/APJCP.2023.24.5.1533.
5
Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancer.肌肉浸润性膀胱癌肿瘤浸润免疫谱的特征。
Front Immunol. 2023 Feb 3;14:986598. doi: 10.3389/fimmu.2023.986598. eCollection 2023.
6
A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer.一种基于结直肠癌中铜死亡相关长链非编码RNA挖掘的新型预后标志物。
Front Genet. 2022 Aug 29;13:969845. doi: 10.3389/fgene.2022.969845. eCollection 2022.
7
Tropomyosin Is Potential Markers for the Diagnosis and Prognosis of Bladder Cancer.原肌球蛋白可作为膀胱癌诊断和预后的潜在标志物。
Dis Markers. 2022 Jun 13;2022:6936262. doi: 10.1155/2022/6936262. eCollection 2022.
8
A novel endoplasmic reticulum stress-related lncRNA prognostic risk model for cutaneous melanoma.一种新型与内质网应激相关的长链非编码 RNA 预测皮肤黑色素瘤预后的风险模型。
J Cancer Res Clin Oncol. 2022 Dec;148(12):3227-3241. doi: 10.1007/s00432-022-04086-y. Epub 2022 Jun 10.
9
OAS3 is a Co-Immune Biomarker Associated With Tumour Microenvironment, Disease Staging, Prognosis, and Treatment Response in Multiple Cancer Types.OAS3是一种与多种癌症类型的肿瘤微环境、疾病分期、预后及治疗反应相关的共同免疫生物标志物。
Front Cell Dev Biol. 2022 May 3;10:815480. doi: 10.3389/fcell.2022.815480. eCollection 2022.
10
Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer.N6-甲基腺苷相关长链非编码RNA特征在膀胱癌预后及肿瘤微环境中的综合分析
Front Oncol. 2022 Jan 24;12:774307. doi: 10.3389/fonc.2022.774307. eCollection 2022.
Tumor‑infiltrating M2 macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer.
特定基因组改变驱动的肿瘤浸润性 M2 巨噬细胞与膀胱癌的预后相关。
Oncol Rep. 2019 Aug;42(2):581-594. doi: 10.3892/or.2019.7196. Epub 2019 Jun 12.
4
Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview.巨噬细胞极化在卵巢癌发生发展中的研究综述
Front Oncol. 2019 May 22;9:421. doi: 10.3389/fonc.2019.00421. eCollection 2019.
5
Identification and validation of an individualized autophagy-clinical prognostic index in bladder cancer patients.膀胱癌患者个体化自噬临床预后指数的识别与验证
Onco Targets Ther. 2019 May 14;12:3695-3712. doi: 10.2147/OTT.S197676. eCollection 2019.
6
Tumor-associated macrophages promote bladder tumor growth through PI3K/AKT signal induced by collagen.肿瘤相关巨噬细胞通过胶原诱导的 PI3K/AKT 信号促进膀胱肿瘤生长。
Cancer Sci. 2019 Jul;110(7):2110-2118. doi: 10.1111/cas.14078. Epub 2019 Jun 19.
7
Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA.临床参数在预测膀胱癌预后方面优于分子亚型:来自多个队列的结果,包括 TCGA。
J Urol. 2020 Jan;203(1):62-72. doi: 10.1097/JU.0000000000000351. Epub 2019 May 21.
8
Correlation of BRCA2 gene mutation and prognosis as well as variant genes in invasive urothelial carcinoma of the bladder.BRCA2 基因突变与预后的相关性及膀胱癌浸润性尿路上皮癌的变异基因。
Cancer Biomark. 2019;25(2):203-212. doi: 10.3233/CBM-182379.
9
Tumor immune microenvironment in non-muscle-invasive urothelial carcinoma of the bladder.膀胱非肌肉浸润性尿路上皮癌的肿瘤免疫微环境。
Hum Pathol. 2019 Jul;89:24-32. doi: 10.1016/j.humpath.2019.04.003. Epub 2019 Apr 24.
10
Tissue-resident memory T cells keep cancer dormant.组织驻留记忆T细胞使癌症保持休眠状态。
Cell Res. 2019 May;29(5):341-342. doi: 10.1038/s41422-019-0156-5.